Finance

Lists
001065:KRX
JW Pharmaceutical(1P) Pref Shs
21 300,00 KRW
0,00%
(0,00) 1D
16 ოქტ, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 001065...
Open
21 300 KRW
High
21 300 KRW
Low
21 100 KRW
Mkt. cap
607,55 მლრ.
Avg. vol.
122,00
Volume
34,00
Dividend
3,05%
Quarterly dividend
162 KRW
Ex-dividend date
27 დეკ. 2023
P/E ratio
5,08
52-wk high
30 300 KRW
52-wk low
19 710 KRW
EPS
4 193 KRW
Shares outstanding
341,95 ათ.
No. of employees
1 ათ.
Open
21 300 KRW
High
21 300 KRW
Low
21 100 KRW
Mkt. cap
607,55 მლრ.
Avg. vol.
122,00
Volume
34,00
Dividend
3,05%
Quarterly dividend
162 KRW
Ex-dividend date
27 დეკ. 2023
P/E ratio
5,08
52-wk high
30 300 KRW
52-wk low
19 710 KRW
EPS
4 193 KRW
Shares outstanding
341,95 ათ.
No. of employees
1 ათ.
News stories
From web sources and news partners
About JW Pharmaceutical(1P) Pref Shs
CEOლი, კიუნგ ჰა
Employees1,05 ათ.
Founded1945
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
200,02 მლრ.
198,94 მლრ.
199,88 მლრ.
222,02 მლრ.
Cost of goods sold
105,39 მლრ.
109,09 მლრ.
101,43 მლრ.
116,73 მლრ.
Cost of revenue
105,39 მლრ.
109,09 მლრ.
101,43 მლრ.
116,73 მლრ.
Research and development expenses
7,33 მლრდ.
15,27 მლრდ.
9,38 მლრდ.
11,86 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55,58 მლრდ.
60,42 მლრდ.
55,91 მლრდ.
59,90 მლრდ.
Operating expense
62,60 მლრდ.
80,98 მლრდ.
64,88 მლრდ.
71,95 მლრდ.
Total operating expenses
167,99 მლრ.
190,07 მლრ.
166,31 მლრ.
188,68 მლრ.
Operating income
32,03 მლრდ.
8,87 მლრდ.
33,58 მლრდ.
33,34 მლრდ.
Other non operating income
-4,64 მლრდ.
8,03 მლრდ.
1,21 მლრდ.
835,27 მლნ.
EBT including unusual items
27,85 მლრდ.
17,49 მლრდ.
35,20 მლრდ.
34,76 მლრდ.
EBT excluding unusual items
27,85 მლრდ.
15,96 მლრდ.
35,20 მლრდ.
34,76 მლრდ.
Income tax expense
-2,74 მლრდ.
2,18 მლრდ.
7,72 მლრდ.
6,86 მლრდ.
Effective tax rate
-9,83%
12,44%
21,93%
19,75%
Other operating expenses
-
-
-
-
Net income
30,59 მლრდ.
15,32 მლრდ.
27,48 მლრდ.
27,89 მლრდ.
Net profit margin
15,29%
7,70%
13,75%
12,56%
Earnings per share
1,27 ათ.
-
-
-
Interest and investment income
-
3,34 მლრდ.
-
-
Interest expense
-
-4,42 მლრდ.
-
-
Net interest expenses
-
-1,09 მლრდ.
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
36,72 მლრდ.
13,65 მლრდ.
38,56 მლრდ.
38,37 მლრდ.
Gain or loss from assets sale
5,12 მლნ.
3,00 ათ.
-10,00 მლნ.
3,00 ათ.
AI content may include mistakes. Learn more
Google აპები